Management of acute myeloblastic leukemia in a child with biallelic mismatch repair deficiency

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 8, 2015, Pages e490-e493

  Elhasid, Ronit ^a   Dvir, Rina ^a   Keidar, Hila Rosenfeld ^a   Shachar, Shay Ben ^a   Bitan, Menachem ^a   Solar, Irit ^a   Durno, Carol ^b   Aronson, Melyssa ^c   Malkin, David ^b   Hawkins, Cynthia ^d   Bouffet, Eric ^b   Tabori, Uri ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b Institute of Medical Science   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Acute myeloblastic leukemia; bMMRD; Bone marrow transplantation

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; NUCLEOPHOSMIN; PROTEIN MSH6; RITUXIMAB; STEM CELL FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; DNA BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; NUCLEAR PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; AXILLARY LYMPHADENOPATHY; BIALLELIC MISMATCH REPAIR DEFICIENCY; BONE MARROW BIOPSY; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; CHROMOSOME 7; CONSANGUINITY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE REDUCTION; ELECTROCARDIOGRAPHY; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC DISORDER; GENETIC SCREENING; GINGIVA HYPERTROPHY; GRAFT VERSUS HOST REACTION; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; INFANT; LEUKEMIA RELAPSE; LEUKOCYTOSIS; LYMPHADENOPATHY; MSH6 GENE; NPM1 GENE; PHYSICAL EXAMINATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN BIOPSY; THROMBOCYTOPENIA; VENTRICULAR NONCOMPACTION; ADVERSE EFFECTS; ALLOGRAFT; BRAIN NEOPLASMS; CAFE-AU-LAIT SPOTS; COLORECTAL NEOPLASMS; DIFFERENTIAL DIAGNOSIS; FATALITY; GENETICS; GERMLINE MUTATION; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MULTIMODALITY CANCER THERAPY; NEOPLASTIC SYNDROMES, HEREDITARY; RECURRENT DISEASE; VIROLOGY;

ALLOGRAFTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CAFE-AU-LAIT SPOTS; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FATAL OUTCOME; FEMALE; GERM-LINE MUTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; NUCLEAR PROTEINS; RECURRENCE;

EID: 84945958510     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000415     Document Type: Article

References (19)

1. Alter BP. Diagnosis, genetics, and management of inherited bone marrow failure syndromes. Hematology Am Soc Hematol Educ Program. 2007;29-39.
2. Zhukova N, Ramaswamy V, Remke M, et al. Subgroupspecific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013;31:2927-2935.
3. Vasen HF, Blanco I, Aktan-Collan K, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut. 2013; 62:812-823.
4. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol. 2006;7:335-346.
5. Wang Q, Lasset C, Desseigne F, et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res. 1999;59:294-297.
6. Ricciardone MD, Ozcelik T, Cevher B, et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res. 1999;59:290-293.
7. Felton KE, Gilchrist DM, Andrew SE. Constitutive deficiency in DNA mismatch repair. Clin Genet. 2007;71:483-498.
8. Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet. 2008;124:105-122.
9. Wimmer K, Kratz CP, Vasen FA, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'Care for CMMRD' (C4CMMRD). J Med Genet. 2014;51:355-365.
10. Vasen HFA, Ghorbanoghli Z, Bourdeaut F, et al. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet. 2014;51: 283-293.
11. Etzler J, Peyrl A, Zatkova A, et al. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudo gene interference. Hum Mutat. 2008;29:299-305.
12. Scott RH, Mansour S, Pritchard-Jones K, et al. Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nat Clin Pract Oncol. 2007;l:130-134.
13. Bakry D, Aronson M, Durno C, et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer. 2014;50:987-996.
14. Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24: 101-122.
15. Rosenberg PS, Alter BP. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica. 2008;93:511-517.
16. Lin CH, Lin WC. Child with ataxia telangiectasia developing acute myeloid leukemia. J Clin Oncol. 2010;28:213-214.
17. Chrzanowska KH, Gregorek H, Dembowska-Bagińska B, et al. Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis. 2012;7:13.
18. Poppe B. Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies. Cancer Genet Cytogenet. 2001;128:39-42.
19. Brems H. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009;10: 508-515.